Location: United States
Total raised: $12.7M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.11.2025 | Seed | $12.7M | Takeda Ven... |
Mentions in press and media 3
| Date | Title | Description |
| 08.11.2025 | Accipiter Biosciences Secures $12.7M Seed Funding, Revolutionizing Protein Therapies | Accipiter Biosciences, a Seattle biotech, exited stealth with $12.7 million in seed funding. The company pioneers de novo multifunctional protein therapeutics. Its computational platform designs novel biologics from scratch. These single mo... |
| 07.11.2025 | Accipiter Biosciences: $12.7 Million Seed Funding Closed To Develop De Novo Protein Therapies | Accipiter Biosciences has emerged from stealth with $12.7 million in seed funding to advance a new class of de novo multifunctional protein therapeutics designed to treat complex diseases. The seed round was co-led by Takeda and Flying Fish... |
| 07.11.2025 | Accipiter Biosciences Raises $12.7M in Seed Financing | Accipiter Biosciences, a Seattle, WA-based biotechnology company developing de novo multifunctional biologics to treat complex diseases, raised $12.7M in Seed funding. The round was co-led by Takeda and Flying Fish Partners, with participat... |